Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Heart Failure With Chronic Kidney Disease - Propensity Score Matching Analysis.
CONCLUSIONS: Prescription of an ACEI or ARB at discharge was associated with reduction in all-cause mortality in patients with acute HF and CKD. Clinicians need to be aware of the prognostic value and consider prescribing ACEI or ARB to high-risk patients.
PMID: 31776309 [PubMed - as supplied by publisher]
Source: Circulation Journal - Category: Cardiology Authors: Kim HJ, Lee MH, Jo SH, Seo WW, Kim SE, Kim KJ, Choi JO, Ahn HS, Choi DJ, Ryu KH Tags: Circ J Source Type: research
More News: Cardiology | Chronic Kidney Disease | Heart | Heart Failure | Study | Urology & Nephrology